Close Menu
Chicago News Journal
    Facebook X (Twitter) Instagram
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Facebook X (Twitter) Instagram YouTube TikTok
    Chicago News JournalChicago News Journal
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • LifeStyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About us
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Privacy Policy
      • Terms and Conditions
    Chicago News Journal
    Home»Politics

    Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump

    AdminBy AdminOctober 14, 2023 Politics
    Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    In this article

    • PFE
    Pfizer CEO Albert Bourla talks during a press conference with the president of the European Commission after a visit to oversee the production of the Pfizer-BioNTech Covid-19 vaccine at the factory of U.S. pharmaceutical company Pfizer, in Puurs, Belgium, April 23, 2021.
    John Thys | AFP | Getty Images

    Pfizer slashed its full-year earnings and revenue guidance on Friday, as it said demand for its Covid products has waned.

    The company now expects 2023 sales of $58 billion to $61 billion, down from its previous guidance of $67 billion to $70 billion. Pfizer said it cut its revenue outlook “solely due to its Covid products.”

    The biopharmaceutical company slashed its full-year adjusted earnings guidance to a range of $1.45 to $1.65 per share, from a previous $3.25 to $3.45 per share.

    Pfizer said it expects revenue from the Covid treatment Paxlovid to come in $7 billion lower than previously anticipated, in part due to the return of doses labeled for emergency use by the U.S. government. It also said it anticipates sales of its vaccine, Comirnaty, will be $2 billion lower than previously expected because of lower-than-expected vaccination rates.

    Pfizer’s latest Covid booster became available in the U.S. last month, but the rollout has been rocky due to supply and insurance coverage issues. Fewer patients have also sought treatments for Covid than they did earlier in the pandemic, as vaccination and prior immunity lead to milder cases for many people.

    Pfizer shares fell more than 3% in extended trading Friday.

    Subscribe to CNBC on YouTube.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    You might also be interested in...

    Could Iran Win the War? By Howard Bloom

    November 13, 2026

    Schumer accuses Trump of defending Nvidia CEO Jensen Huang at cost of national security

    November 10, 2026

    House Oversight calls on DOJ to interview key Epstein witnesses, says govt. failed survivors

    November 10, 2026

    Pete Hegseth decries impeachment push, defends Iran war handling

    November 10, 2026

    France blames Iran for supermarket refrigerator cyberattacks, weighs sanctions

    November 10, 2026

    Trump sees opening for Ukraine peace deal, but key questions remain ahead of Abu Dhabi talks

    November 10, 2026
    Popular Posts

    How to tell a cyberattack from a plain old outage

    Movie Review: Elsinore

    Interview with Aletheia von Gottlieb, Author of Love Off the Ice (Sweet Snowfall Kisses Book 1) – NewInBooks

    What Were Wearing: Friendsgiving

    In historic move, House Democrats nominate Hakeem Jeffries for speaker of the House

    Book Riots Deals of the Day for November 18, 2026

    Categories
    • Books (2,457)
    • Business (3,449)
    • Events (34)
    • Film (1,062)
    • LifeStyle (2,922)
    • Music (2,796)
    • Politics (2,355)
    • Science (1,952)
    • Technology (1,817)
    • Television (3,628)
    • US News (3,294)
    Archives
    Useful Links
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Popular Posts
    • U.S. begins blockade of Strait of HormuzU.S. begins blockade of Strait of Hormuz
    • FDA fast-tracks psychedelic drug research following Trump orderFDA fast-tracks psychedelic drug research following Trump order
    • Here’s where the jobs are for July — in one chartHere’s where the jobs are for July — in one chart
    • ‘Criminal Minds: Evolution’: What Happened to Voit & More Questions for Season 18‘Criminal Minds: Evolution’: What Happened to Voit & More Questions for Season 18
    • Snapchat Simplifies Location Sharing, Improves Blocking Feature to Protect Younger UsersSnapchat Simplifies Location Sharing, Improves Blocking Feature to Protect Younger Users
    Archives
    Categories
    • Books
    • Business
    • Events
    • Film
    • LifeStyle
    • Music
    • Politics
    • Science
    • Technology
    • Television
    • US News
    Facebook X (Twitter) Instagram YouTube TikTok
    © 2026 Chicago News Journal. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.